title: Cancer Immunotherapy Researchers Focus on Refining Checkpoint Blockade Therapies.
authors.forename: Julie A
authors.initials: JA
authors.lastname: Jacob
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D060908:CTLA-4 Antigen / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D000074324:Ipilimumab; D051379:Mice; D009154:Mutation / Q000276:immunology; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D000077594:Nivolumab; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D060908:CTLA-4 Antigen; D000074324:Ipilimumab; D000077594:Nivolumab